Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
Authors: Farinati F
Date: Apr 16, 2023
Scope of interest: hepatological
06 99 39
Recup number
You may also be interested in:
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.
Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.
Date: 2022
Scope of interest: Epilepsy
Read details
“Writingepilepsy” with atypical characteristics: crisis reflected in ‘copied writing’
Authors: A. Morano, J. Fattouch, S. Casciato, L. Lapenta, M. Fanella, R. Tomassi, A.T. Giallonardo, C. Di Bonaventura
Date: 2016
Scope of interest: Epilepsy
Read details
Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid-19.
Authors:
Date: 2020
Scope of interest: Neurology/emergency
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
